10 Best Immunotherapy Stocks To Buy Now
The global immunotherapy market is rapidly evolving as technological, regulatory, and economic trends combine to alter the growth and risk dynamics within the industry.
Urogen Pharma Ltd. (URGN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Wildcat Capital Management Leonard A. Potter | 533,139 | $4,728,943 | 1.8% | |
| 2. | ARK Investment Management Catherine D. Wood | 196,938 | $1,746,840 | -31% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.10 | 160 | Officer | 21,997 | 2021-11-18 | Filing | |
| $15.85 | 2,500 | Officer | 2,500 | 2021-05-17 | Filing | |
| $15.71 | 2,500 | Officer | 2,500 | 2021-05-17 | Filing | |
| $18.50 | 10,000 | Officer | 229,117 | 2020-12-14 | Filing | |
| $28.00 | 7,530 | Officer | 16,548 | 2019-11-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.12 | 1,227 | Officer | 13,873 | 2023-01-31 | Filing | |
| $10.12 | 409 | Officer | 12,600 | 2023-01-31 | Filing | |
| $10.12 | 661 | Officer | 148,560 | 2023-01-31 | Filing | |
| $10.12 | 991 | Officer | 147,888 | 2023-01-31 | Filing | |
| $10.12 | 248 | Officer | 146,879 | 2023-01-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 136,835 | $1,183,934 | 0.02% | |
| 2. | 72,931 | $646,898 | 0.03% | |
| 3. | 10,511 | $93,233 | 0% | |
| 4. | 1,025,560 | $9,097 | 0.19% | |
| 5. | 698,302 | $6,194 | 0.13% |
News See All
10 Micro-Cap Stocks To Buy According To Cathie Wood
In this article, we discuss the 10 micro-cap stocks to buy according to Cathie Wood.
10 Micro-Cap Stocks to Buy According to Cathie Wood
In this article, we discuss the 10 micro-cap stocks to buy according to Cathie Wood.
Here is What Hedge Funds Think About UroGen Pharma Ltd. (URGN)
In this article we are going to use hedge fund sentiment as a tool and determine whether UroGen Pharma Ltd. (NASDAQ:URGN) is a good investment right now.
Hedge Funds Aren't Crazy About UroGen Pharma Ltd. (URGN) Anymore
Is UroGen Pharma Ltd.
Hedge Funds Are Selling UroGen Pharma Ltd. (URGN)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
Is UroGen Pharma Ltd. (URGN) A Good Stock To Buy?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Hedge Funds Have Never Been This Bullish On UroGen Pharma Ltd. (URGN)
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money because...
Is UroGen Pharma Ltd. (URGN) A Good Stock To Buy?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter. NASDAQ and Russell 2000 indices were already in correction territory.
Is UroGen Pharma Ltd. (URGN) A Good Stock To Buy?
At Insider Monkey, we pore over the filings of more than 700 top investment firms every quarter, a process we have now completed for the latest reporting period.
Billionaire Hedge Funds
